Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

RAPT Therapeutics, Inc. (RAPT)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Visitors trend2W10W9M
16.76+0.48 (+2.95%)
At close: 04:00PM EST
17.15 +0.39 (+2.33%)
After hours: 04:14PM EST
Advertisement
Advertisement
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Total Revenue
2,283
3,813
5,042
0
0
Operating Expense
81,681
73,022
58,256
43,629
36,947
Operating Income
-79,398
-69,209
-53,214
-43,629
-36,947
Other Income Expense
582
5
1,312
1,292
800
Pretax Income
-78,816
-69,204
-51,902
-42,337
-36,147
Tax Provision
-
0
990
660
-
Net Income Common Stockholders
-78,816
-69,204
-52,892
-42,997
-36,147
Diluted NI Available to Com Stockholders
-78,816
-69,204
-52,892
-42,997
-36,147
Basic EPS
-
-2.53
-2.19
-9.89
-2.50
Diluted EPS
-
-2.53
-2.19
-9.89
-2.50
Basic Average Shares
-
27,390
24,134
4,346
14,461
Diluted Average Shares
-
27,390
24,134
4,346
14,461
Total Operating Income as Reported
-79,398
-69,209
-53,214
-43,629
-36,947
Total Expenses
81,681
73,022
58,256
43,629
36,947
Net Income from Continuing & Discontinued Operation
-78,816
-69,204
-52,892
-42,997
-36,147
Normalized Income
-78,816
-69,204
-52,892
-42,997
-36,147
EBIT
-79,398
-69,209
-53,214
-43,629
-36,947
EBITDA
-78,372
-
-
-
-
Reconciled Depreciation
1,026
996
1,123
1,330
1,237
Net Income from Continuing Operation Net Minority Interest
-78,816
-69,204
-52,892
-42,997
-36,147
Normalized EBITDA
-78,372
-68,213
-52,091
-42,299
-35,710
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
Advertisement
Advertisement